首页> 外文期刊>Daruha-yi Giyahi >The examination of intellectual right of medicinal plants and the issue of bio-theft due to agreement of TRIPS
【24h】

The examination of intellectual right of medicinal plants and the issue of bio-theft due to agreement of TRIPS

机译:TRIPS协议对药用植物知识产权的审查和生物盗窃问题

获取原文
           

摘要

Over the past two decades, the role of intellectual property rights in all areas of science and technology has exploded globallya?? primarily due to the rules prescribed by the World Trade Organizationa??s TRIPS and by bilateral/regional trade agreements. The TRIPS agreement obligates all WTO member countries to adopt and enforce minimum standards of intellectual property rights. The TRIPS agreement requires member countries to make patents available for inventions, whether products or processes, in all fields of technology without discrimination, subject to the standard patent criteria (novelty, inventiveness and industrial applicability). During the negotiations on the TRIPS agreement, consensus was not reached on the controversial area of biotechnological inventions. The US and some other developed countries pushed for no exclusions to patentability, while some developing country members preferred to exclude all biological diversity-related inventions from IP laws. For many developing countries the patenting of life forms and exclusive monopoly protection on biological products and processes that originate in developing countries (or that are based on traditional knowledge) continues to be controversial. The major genetic resources are in the southern states and so, many companies are seeking to access to genes, microbes, plants, animals and even native human populations to seize them as a monopoly product. Critics call the establishment of intellectual property rights to these resources for the industrial countries biopiracy and know the obligation of developing nations to pay royalties to wealthy industrial countries for the products that obtained from their own genetic resources and traditional knowledge a??biological colonialisma??. Pharmaceutical industries are the biggest thieves of genetic and natural resources at the international level. This is the third world countries' responsibility while preserving their vital resources and reserves, ensure optimal use of these natural blessings.
机译:在过去的二十年中,知识产权在科学和技术的所有领域中的作用在全球范围内激增了?主要是由于世界贸易组织的TRIPS和双边/区域贸易协定所规定的规则。 TRIPS协议规定所有WTO成员国都有义务采用和执行最低限度的知识产权标准。 TRIPS协议要求成员国在标准技术标准(新颖性,创造性和工业实用性)的前提下,不加歧视地为所有技术领域的发明(无论是产品还是工艺)提供专利。在关于TRIPS协定的谈判中,在有争议的生物技术发明领域未达成共识。美国和其他一些发达国家不要求排除可专利性,而一些发展中国家成员则希望将所有与生物多样性相关的发明排除在知识产权法之外。对于许多发展中国家而言,生命形式的专利和对源自发展中国家(或基于​​传统知识的)生物产品和过程的专有垄断保护仍然存在争议。主要的遗传资源位于南部各州,因此,许多公司都在寻求获取基因,微生物,植物,动物乃至本地人口的机会,以将其作为垄断产品来获取。批评者呼吁为工业化国家的生物海盗行为建立对这些资源的知识产权,并知道发展中国家有义务向富裕的工业国支付从其自身的遗传资源和传统知识获得的产品的特许权使用费,即“生物殖民主义”。 。制药行业是国际上最大的遗传资源和自然资源盗贼。这是第三世界国家的责任,同时保留其重要资源和储备,确保最佳利用这些自然祝福。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号